Associated Papers
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.
Gbyli R et al.
Leukemia, 2022
35273342 (PubMed )
Supplement: NIHMS1782098-supplement-Supplemental_material.pdf
Select a paper to view details